Literature DB >> 12196194

Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth.

O Kakhlon1, Y Gruenbaum, Z I Cabantchik.   

Abstract

We assessed the role of the cell labile iron pool in mediating oncogene-induced cell proliferation via repression of ferritin expression. When HEK-293 cells, engineered to inducibly express either active (+) or dominant-negative (-) forms of the H-ras oncogene, were treated with antisense nucleotides to ferritin subunits they displayed (a) decreased ferritin levels, (b) increased labile iron pool and either (c) faster growth in cells induced to express H-Ras (+) or (d) recovery from growth retardation in dominant-negative H-Ras-induced cells. Our studies support the view that the role of down-modulation of ferritin expression by some oncogene-evoked proliferation proceeds via expansion of the cellular labile iron pool.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196194     DOI: 10.1042/bst0300777

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  12 in total

Review 1.  Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.

Authors:  Shenghang Wang; Jie Luo; Zhihao Zhang; Dandan Dong; Ying Shen; Yanwen Fang; Lijiang Hu; Mengyu Liu; Chengfu Dai; Songlin Peng; Zhicai Fang; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

2.  Regulation of ferroptotic cancer cell death by GPX4.

Authors:  Wan Seok Yang; Rohitha SriRamaratnam; Matthew E Welsch; Kenichi Shimada; Rachid Skouta; Vasanthi S Viswanathan; Jaime H Cheah; Paul A Clemons; Alykhan F Shamji; Clary B Clish; Lewis M Brown; Albert W Girotti; Virginia W Cornish; Stuart L Schreiber; Brent R Stockwell
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

3.  Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest.

Authors:  Fan Zhang; Wei Wang; Yoshiaki Tsuji; Suzy V Torti; Frank M Torti
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

Review 4.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

Review 5.  Iron and Cancer: 2020 Vision.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

6.  Epigenomic regulation by labile iron.

Authors:  Vladimir Camarena; Tyler C Huff; Gaofeng Wang
Journal:  Free Radic Biol Med       Date:  2021-01-22       Impact factor: 8.101

7.  Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells.

Authors:  Stephanie Rockfield; Idhaliz Flores; Meera Nanjundan
Journal:  Oncotarget       Date:  2017-12-28

Review 8.  Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.

Authors:  Alessandro Fanzani; Maura Poli
Journal:  Int J Mol Sci       Date:  2017-08-07       Impact factor: 5.923

Review 9.  The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis.

Authors:  Naiara Santana-Codina; Ajami Gikandi; Joseph D Mancias
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  miR-20a regulates expression of the iron exporter ferroportin in lung cancer.

Authors:  Kamesh R Babu; Martina U Muckenthaler
Journal:  J Mol Med (Berl)       Date:  2015-11-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.